SUMMARY In an attempt to determine the presence or absence of correlation between the intraocular pressure-increasing and pupil-dilating effects of corticosteroids, the effect of topically applied dexamethasone and various autonomic agents has been studied in 12 hospitalised, healthy, young adult volunteers. Dexamethasone caused an average increase of intraocular pressure of 8-8 mmHg and of pupillary diameter of 0-36 mmHg; there was no significant correlation between the change in pressure and the change in pupil size. Furthermore, there was no correlation between magnitude of rise of intraocular pressure and miotic effect of methacholine 2 5 %, or mydriatic effect of epinephrine 0 I%, or norepinephrine 0 1%. Dexamethasone-treated eyes showed a greater decrease in pupillary diameter in response to methacholine than their untreated mates (-1I14 and -0-68 mm respectively) and a slightly smaller increase in response to epinephrine than their controls (-0 18 and -0 53 respectively). Methacholine caused an increase in intraocular pressure of 2-8 mmHg in control eyes and 6-0 mmHg in dexamethasone-treated eyes. Increases of less significance were caused by epinephrine and norepinephrine. Subjects with the largest rise of intraocular pressure in response to dexamethasone also showed the greatest increase in intraocular pressure in response to the autonomic agents and to the water drinking test. Furthermore, they had lower coefficients of aqueous outflow than those having smaller responses. Methacholine 2-5 % produced miosis in over 50 % of normal control eyes.
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Dilatation of the pupil occurs in many individuals receiving topical corticosteroids.1 An increase of intraocular pressure has also been noted in many of them, but there does not appear to be a correlation between dilatation of the pupil and rise in pressure.2-4 The purpose of the present study was to attempt to determine if sensitivity to agents of the sympathetic or parasympathetic nervous system (1) accounts for the pupillary dilatation or (2) plays a role in the increase of intraocular pressure seen in corticosteroid-treated patients.
Materials and methods
Twelve normal college students ranging in age from 17 to 21 were studied. They were admitted to hospital for the entire duration of the study. The Throughout the study intraocular pressure was measured daily and tonography performed weekly. In some subjects frequency of administration of dexamethasone was decreased when it became apparent that 5 drops a day was producing an excessive rise in intraocular pressure.
Results
Dexamethasone 01 0%, 4 or 5 times a day, produced an average increase of intraocular pressure of 8-8 mmHg (Table 1 ). There was no significant change in coefficient of aqueous outflow (C) ( Table  1 ). The intraocular pressure and coefficient of aqueous outflow of the untreated eyes did not change significantly (Table 1) .
Though almost all subjects had a slight increase in the size of the pupil of the dexamethasonetreated eye, this was frequently transient. Average pupil size of treated eyes was 5-20 mm and untreated eyes (4-84 mm (Table 2 ). There was no correlation between the increase in the size of the pupil caused by the topical dexamethasone and the concurrent rise of intraocular pressure. Ptosis and temporarily blurred vision were noted occasionally, but no serious side effects occurred. Administration of several of the autonomic nervous system drugs produced changes in intraocular pressure as well as in pupillary size (Tables  2 and 3 ). When these alterations were biphasic, both the greatest and the smallest values were recorded and averaged separately in the statistical analysis. The tables include only the predominant changes.
The miotic effect of methacholine 2-5% was small but definite. 47% of control eyes had no change in pupil size, 31 % a 1 mm decrease, 19% a 2 mm decrease, and 3% a 3 mm decrease. Responsiveness was accentuated by pretreatment with (Table 4 ).
This responsiveness may be related to the freshness of the solution used, for methacholine is unstable in solution and in the present study was prepared immediately prior to administration.
It was of interest that eyes most sensitive to the ocular hypertensive effect of dexamethasone reacted most markedly to the other tests employed in the present study; they showed the greatest intraocular pressure response to methacholine, epinephrine, norepinephrine, and the water drinking test (Table   5 ). In fact the 3 groups in Table 5 behave differently (Table 5) . This close correlation between the ocular hypertensive effect of dexamethasone and the ocular hypertensive effect of the various autonomic agents forms an intriguing contrast to the lack of relationship between dexamethasone-induced rise in pressure and pupil size and the similar lack of relationship between rise of pressure and sensitivity to the pupillary effects of several autonomic agents. Those eyes sensitive to the intraocular pressure-inducing effect of corticosteroids were also more sensitive to other external (and perhaps internal) stimuli that effect intraocular pressure. As such these eyes may be manifesting what has classically been considered one of the characteristics of the glaucomatous eye. 
